FDA is committed to protecting national health and security. We are working to foster the development and availability of medical products that will be needed to counter a public health emergency, no matter its origin.
The FDA Medical Countermeasures Initiative (MCMi) mission has three main components:
Public Health and Security Action Teams promote the development and availability of medical countermeasures (MCMs) by establishing clear regulatory pathways. A robust MCM regulatory science program creates the data necessary to support regulatory decision-making A collaborative effort to modernize the legal, regulatory and policy framework establishes effective policies and mechanisms to facilitate timely access to available MCMs